Evidence-led comparison

Urolithin A vs Spermidine: targeted or broad recycling.

Read the verdict
60
Combined US searches / month
100
Participants in SmartAge
12
Months studied
Close view of cellular material representing autophagy and mitophagy

The short answer

Different tools for different biological jobs.

Spermidine is the broader candidate for people interested in general autophagy biology and emerging cognitive or cardiovascular research, although larger human trials have produced mixed results. Urolithin A is the more targeted choice for mitochondrial quality and muscle-aging priorities, particularly through mitophagy activation, selected randomized human muscle outcomes, and consistent delivery independent of gut-microbiome conversion.

At a glance

Urolithin A and Spermidine, side by side.

The comparison is organized by biological role, evidence maturity, and the outcomes each ingredient is best positioned to support.

DimensionUrolithin ASpermidineBottom line
Primary roleActivates mitophagy, selective recycling of damaged mitochondriaInfluences broader autophagy and metabolic signalingTargeted versus broad cellular recycling
Best-established human outcomesSelected muscle endurance, strength, and mitochondrial biomarkersHuman outcome evidence is mixed; cognition is a major research focusUrolithin A has clearer randomized muscle outcomes
Evidence baseSeveral randomized trials and a human systematic reviewStrong preclinical rationale and a smaller intervention baseMechanistic promise exceeds clinical certainty for spermidine
Typical studied intake500–1,000 mg dailyHuman studies use varied extracts and dosesProducts and doses are not interchangeable
Food relationshipProduced by some microbiomes from ellagitannins; conversion variesPresent in foods including wheat germ, soybeans, and mushroomsDietary exposure differs substantially
Most relevant goalMitochondrial quality, muscle endurance, healthy agingBroad autophagy interest and exploratory cognition researchGoal and evidence tolerance determine fit

Mechanisms

How the biology differs.

Urolithin A

Selective mitochondrial recycling

Urolithin A activates mitophagy through pathways including PINK1/Parkin. Randomized human trials have studied mitochondrial biomarkers and muscle outcomes.

Spermidine

Broader cellular recycling

Spermidine is associated with wider autophagy-related signaling, including pathways involving AMPK and sirtuins, and has extensive preclinical research across aging biology.

Human evidence

What the studies show—and what they do not.

Urolithin A evidence

Selected randomized muscle outcomes

Trials reported improvements in selected strength or endurance measures and favorable biomarkers. Several primary functional endpoints did not significantly improve, so broad anti-aging claims are not supported.

Spermidine evidence

Promising pilot, negative larger primary outcome

A small pilot reported improved memory measures. The larger 12-month SmartAge trial did not significantly improve its primary memory outcome or secondary outcomes versus placebo; exploratory signals require validation.

Choosing by goal

Start with the outcome, not the ingredient.

Choose Spermidine when the priority is:

  • Exploring broader autophagy biology rather than mitochondria alone
  • Following emerging cognition and cardiovascular-aging research
  • Favoring a compound naturally present across multiple foods
  • Accepting mixed human findings and unresolved dose questions

Consider Urolithin A when the priority is:

  • Targeting mitochondrial quality control through mitophagy
  • Muscle endurance and healthy-aging goals
  • An ingredient tested in multiple randomized human trials
  • A consistent dose independent of microbiome conversion

Where Mitopure fits.

Mitopure® is Amazentis’ proprietary, highly pure form of Urolithin A used in published human clinical studies. It provides a consistent dose for targeted mitophagy support. Spermidine has a broader autophagy hypothesis, but its human supplementation evidence remains less consistent for specific functional outcomes.

References

The evidence behind this comparison.

Common questions

Urolithin A and Spermidine.

A hand preparing a measured dose of Mitopure

Bring the science home with Timeline.

Explore Mitopure
#1

Clinically studied

Urolithin A

The Swiss life-science company pioneering Urolithin A, advancing the science of cellular longevity since 2007.

Contact

EPFL Innovation Park, Bâtiment C
1015 Lausanne, Switzerland
contact@amazentis.com

* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

References: Our clinical study showed that sedentary, middle-aged adults with an average BMI of 29.52 increased hamstring muscle strength. Nutrition NOURISH Study: 500mg Mitopure® have been shown to deliver at least 6 times higher Urolithin A plasma levels over 24 hours (area under the curve) than 8 ounces (240ml) of pomegranate juice in a randomized human clinical trial.